Jianhua Sui Selected Research

Jianhua Sui Research Topics

Disease

22	Infections 02/2024 - 03/2003
11	Neoplasms (Cancer) 01/2023 - 01/2012
6	Virus Diseases (Viral Diseases) 02/2024 - 11/2012
6	Human Influenza (Influenza) 12/2017 - 12/2010
6	Hepatitis B 09/2015 - 11/2012
5	Severe Acute Respiratory Syndrome 11/2006 - 11/2003
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2016
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2020
2	Carcinogenesis 12/2017 - 01/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2012 - 01/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2006 - 03/2005
1	COVID-19 12/2023
1	Disease Progression 01/2023
1	Vitiligo 01/2022
1	Genetic Translocation (Chromosomal Translocation) 01/2020
1	Focal Nodular Hyperplasia 01/2019
1	Reinfection 01/2019
1	Chronic Hepatitis B 12/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2017
1	Starvation 08/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Hepatitis D 04/2015
1	Coronavirus Infections 12/2014
1	Superinfection 05/2008
1	Autoimmune Diseases (Autoimmune Disease) 08/2007

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2003
9	AntibodiesIBA 02/2024 - 12/2005
7	Antiviral Agents (Antivirals)IBA 01/2023 - 02/2004
7	sodium-bile acid cotransporterIBA 01/2018 - 11/2012
6	Amino Acids FDA Link 01/2020 - 11/2012
6	EpitopesIBA 06/2011 - 05/2005
4	Peptides (Polypeptides)IBA 01/2020 - 12/2010
4	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018 - 07/2013
4	VaccinesIBA 12/2017 - 05/2006
4	Broadly Neutralizing AntibodiesIBA 12/2014 - 01/2011
3	AntigensIBA 02/2024 - 01/2017
3	Hemagglutinins (Hemagglutinin)IBA 12/2017 - 01/2011
3	Neutralizing AntibodiesIBA 01/2017 - 05/2006
3	Monoclonal AntibodiesIBA 10/2016 - 05/2005
2	Nasal SpraysIBA 12/2023 - 01/2023
2	Immunoglobulin M (IgM)IBA 12/2023 - 01/2023
2	Chimeric Antigen ReceptorsIBA 01/2023 - 06/2016
2	CytokinesIBA 01/2023 - 01/2016
2	Bile Acids and Salts (Bile Acids)IBA 05/2020 - 03/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 09/2015
2	RNA (Ribonucleic Acid)IBA 10/2016 - 04/2015
2	LigandsIBA 11/2012 - 03/2005
2	trichostatin A (A 300)IBA 10/2006 - 03/2005
2	Death Domain ReceptorsIBA 10/2006 - 03/2005
2	Bortezomib (Velcade)FDA Link 10/2006 - 03/2005
1	Therapeutic UsesIBA 01/2023
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2023
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2023
1	InterferonsIBA 01/2022
1	ChemokinesIBA 01/2022
1	N-end cysteine peptide tumor-homing peptideIBA 11/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	GlypicansIBA 01/2021
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Circular DNAIBA 01/2019
1	Polycomb-Group ProteinsIBA 12/2017
1	Cyclin D1IBA 08/2017
1	Messenger RNA (mRNA)IBA 08/2017
1	Viral DNAIBA 01/2017
1	Lysine (L-Lysine)FDA Link 10/2016
1	B7-H1 AntigenIBA 06/2016
1	Granzymes (Granzyme)IBA 06/2016
1	Carbonic Anhydrase IXIBA 06/2016
1	Immunoglobulin G (IgG)IBA 06/2016
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	CarcinogensIBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2015
1	EnzymesIBA 12/2015
1	Glycoproteins (Glycoprotein)IBA 07/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 07/2015
1	sialate O-acetylesteraseIBA 07/2015
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 04/2015
1	Hepatitis delta Antigens (HDAg)IBA 04/2015
1	SodiumIBA 03/2014
1	Complement System Proteins (Complement)IBA 11/2012
1	Chemokine ReceptorsIBA 11/2012
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2011
1	Viral HemagglutininsIBA 12/2010
1	SARS-CoV spike glycoproteinIBA 11/2008
1	Viral ProteinsIBA 05/2008
1	Neuraminidase (Sialidase)IBA 05/2008
1	Zanamivir (Relenza)FDA Link 05/2008
1	oseltamivir carboxylateIBA 05/2008
1	Tyrosine (L-Tyrosine)FDA Link 08/2007
1	Proteasome InhibitorsIBA 10/2006
1	Fluorouracil (Carac)FDA LinkGeneric 10/2006

Therapy/Procedure

14	Therapeutics 01/2023 - 03/2003
4	Immunotherapy 01/2023 - 11/2012
2	Drug Therapy (Chemotherapy) 10/2006 - 03/2005
1	Intravenous Infusions 01/2012